An online study to change perceptions of asthma and asthma medication in adults

Reframing asthma and inhaled corticosteroids to modify treatment beliefs: an online randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN70438411

Enrollment

733

Registered

2018-11-30

Start date

2017-11-13

Completion date

Unknown

Last updated

2020-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma (including people without asthma as a proxy group for newly diagnosed patients) Respiratory Asthma

Interventions

Participants within each cohort were randomised using the computerised block randomisation function in Qualtrics online survey software. All participants received information about asthma and its trea

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. At least 18 years old 2. Having been diagnosed with asthma for the asthma patient arm of the study

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

Measure	Time frame
Participants' beliefs about inhaled corticosteroids are assessed using the Beliefs about Medicines Questionnaire Speci?c Asthma version (BMQ-S, Horne & Weinman 2002), a 11-item questionnaire used to measure beliefs about the personal need for ICS and the concerns about the potential adverse consequences of ICS. Measurements taken at baseline (asthma cohort only), immediately post-intervention and two-week follow-up.	—

Measure

Time frame

Participants' beliefs about inhaled corticosteroids are assessed using the Beliefs about Medicines Questionnaire Speci?c Asthma version (BMQ-S, Horne & Weinman 2002), a 11-item questionnaire used to measure beliefs about the personal need for ICS and the concerns about the potential adverse consequences of ICS. Measurements taken at baseline (asthma cohort only), immediately post-intervention and two-week follow-up.

—

Secondary

Measure	Time frame
1. Medication adherence/adherence intention: people in the asthma cohort fill out the 10-item version of the Medication Adherence Report Scale (MARS; Horne, Weinman, & Hankins, 1999) at baseline and 2-week follow-up, and an adherence intention measure immediately post-intervention. The cohort without asthma completes the adherence intention measure immediately post-intervention and at 2-week follow-up. 2. Whether the information provided by the intervention had been understood and found to be coherent, whether perceptions about potential side-effects were reduced, whether efficacy beliefs about ICS were increased and perceptions of self were positively altered. Measured using visual analogue scales immediately post-intervention and at 2-week follow-up. 3. Beliefs about asthma, measured using the Illness Perceptions Questionnaire brief version (B-IPQ; Moss-Morris et al., 2002) at baseline, immediately post-intervention and 2-week follow-up.	—

Measure

Time frame

1. Medication adherence/adherence intention: people in the asthma cohort fill out the 10-item version of the Medication Adherence Report Scale (MARS; Horne, Weinman, & Hankins, 1999) at baseline and 2-week follow-up, and an adherence intention measure immediately post-intervention. The cohort without asthma completes the adherence intention measure immediately post-intervention and at 2-week follow-up. 2. Whether the information provided by the intervention had been understood and found to be coherent, whether perceptions about potential side-effects were reduced, whether efficacy beliefs about ICS were increased and perceptions of self were positively altered. Measured using visual analogue scales immediately post-intervention and at 2-week follow-up. 3. Beliefs about asthma, measured using the Illness Perceptions Questionnaire brief version (B-IPQ; Moss-Morris et al., 2002) at baseline, immediately post-intervention and 2-week follow-up.

—

Countries

Australia, Canada, Guernsey, Ireland, Malta, New Zealand, United Kingdom, United States of America

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026